GeneProof
Automated PCR Solution for Every Laboratory Workflow

Throughout the COVID-19 pandemic, polymerase chain reaction or PCR technique has become a widely known term for the general population. But quite interestingly, PCR has persisted as a noble DNA sequencing method for almost 35 years and there are only a handful of technological advancements that can compete with the importance of PCR in laboratory biology. Nonetheless, researchers, engineers, and physicians are still finding ways to propel it into new territories. Automated PCR tests, for example, are now being considered for providing a flexible and user-friendly solution to laboratories and allowing them to analyse clinical samples better.

In this regard, the company that is making the most strides is GeneProof. It is a biotechnology company operating in the field of molecular in vitro diagnostics of serious infections and genetic diseases. Under the leadership of Chairman and CEO, Radek Horvath, GeneProof develops, produces, and distributes technologically advanced, high quality, user-friendly, and affordable PCR products.

What differentiates GeneProof from other contemporary solution providers is the company’s extensive experience in the areas of automation PCR testing and laboratory workflow. Having helped countless clients overcome their laboratory workflow problems, GeneProof understands the typical challenges laboratories face with clinical samples, and as such, GeneProof tries to resolve these hurdles proactively for its clients. In addition to that, GeneProof offers a suite of additional solutions including a semi-automated and fully automated PCR system to help laboratories not only meet clinical targets but also surpass them.

Under the Hood of GeneProof

At the core of GeneProof’s automated PCR kits is the company’s myCROBE system, a fully automated sample-to-result solution with a broad spectrum of diagnostic tests.

GeneProof develops, produces, and distributes technologically advanced, high quality, user-friendly, and affordable PCR products

The system covers the whole process from nucleic acid extraction, PCR setup (including automatic PCR plate sealing), PCR amplification to all the way through to automatic result evaluation. Working alongside myCROBE is croBEE RT, fully integrated nucleic acids and PCR system with the capacity of 96 samples designed PCR amplification and detection along with analysis of obtained data. The croBEE works with the Peltier elements. The fluorescence signal is detected by a highly sensitive optical array detecting a wide range of fluorescence. Thanks to systems managing optical and temperature parameters, high detection accuracy and high results reproducibility are ensured. Notably, these PCR kits can cater to a vast range of diagnoses, including bloodborne infections, immunocompromised, sexually transmitted infections, and thrombotic resistance.

Today, as the COVID-19 pandemic is generating demand for more autonomous and robust PCR testing systems, GeneProof is experiencing a high demand for its robust automation application. And GeneProof is ready to take this challenge head-on, fortified with its rich and extensive experience in the domain and continue to conceptualise and create a lasting impression in the industry. As such, the company has already released a solution based on the sample collection from the nose or mouth (saliva sample) using the sampling kit Bi-CoV, which can be used with GeneProof PCR kits without the need for RNA extraction. It helps laboratories in quick access of samples, reduced risk of infection for laboratory staff, significant time reduction in analysing less than one hour. With many similar innovative PCR systems, GeneProof is now determined to create a safer and healthier tomorrow.